5-HTP Efficacy and Contraindications [Expression of Concern]
Authors Hinz M, Stein A, Uncini T
Received 14 April 2020
Accepted for publication 14 April 2020
Published 23 April 2020 Volume 2020:16 Pages 1059—1060
Hinz M, Stein A, Uncini T. Neuropsychiatr Dis Treat. 2012;8:323– 328.
The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article.
Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors and alleged excessive self-citation for the published article. Neuropsychiatric Disease and Treatment would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation.
The authors have been informed of these concerns and of our investigation.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]